Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Why should I use sharewise

Agilent Technologies Inc. Stock

Price
Target price
€63.80

€63.80

-1.440%
-0.94
-1.440%
€74.33

€74.33

 
Latest predictions
€125.00
10.12.19
buy
€81.00
18.06.19
buy
€67.65
16.01.19
buy
€64.94
09.09.18
buy
Your prediction

Agilent Technologies Inc. Stock

A loss of -1.440% shows a downward development for Agilent Technologies Inc..
Our community is currently high on Agilent Technologies Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of €74.00 there is a slightly positive potential of 15.987% for Agilent Technologies Inc. compared to the current price of €63.80.

Comments

Published 10.12.19
Prediction Buy
Perf. (%) -14.525%
Target price 125.000
Change

Buy with target price 125.0

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Agilent Technologies Inc. Stock

New thread

News

Agilent Technologies Announces Cash Dividend of 18 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on April 22, 2020, to all shareholders of record as of the close of

Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020


Agilent Technologies, Inc. (NYSE: A) today announced plans to adjourn its annual meeting of stockholders, originally scheduled to be held March 18, 2020, due to public health considerations

Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring


Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for laboratories seeking increased

Agilent Receives Two Scientists’ Choice Awards


Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product

Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research


Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.



The new Agilent

Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions


Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a co-marketing agreement. The announcement is happening at the USCAP 109th Annual Meeting being held

Agilent Technologies Announces Webcasts for Investment Community


Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.



40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m

Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core(1) basis).



On a GAAP basis

Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation


Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims

Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics


Agilent Technologies Inc. (NYSE: A) today announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research.



Agilent and IIT

Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call


Agilent Technologies, Inc. (NYSE: A) will release first-quarter fiscal year 2020 financial results after the stock market closes on Feb. 18. The company will also host a live webcast of its

Agilent Introduces New Cutting-Edge SureSelect DNA Kit


Agilent Technologies Inc. (NYSE: A) today introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. The new

Agilent Announces CrossLab Group Leadership Transition


Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020. The company has

Agilent Wins Multiple Innovation Awards


Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards.

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema


Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic

Agilent Expands Cross-Vendor CDS Instrument Control


Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can

Agilent Compliance Services Voted No. 1 in Global Survey


Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.



Cell

 Agilent Technologies to Present at J.P. Morgan Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced the following presentation will be webcast for the investor community:



What: 38th Annual J.P. Morgan Healthcare Conference



Where: The Westin

Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China


Agilent Technologies, Inc. (NYSE: A) today announced it has been selected as one of the top four “Best Workplaces™ in Greater China” by the Great Place to Work® (GPTW) Institute. The company has

Agilent Receives Multiple Life Science Industry Awards for Innovation


Agilent Technologies Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the

Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.37 billion for the fourth quarter ended Oct. 31, 2019, up 6% year over year (core(1) growth of 4%).



On a GAAP basis

Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)


Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union.



The assay is CE-IVD–marked as an aid in

Agilent Announces Applications Open for LabCentral Golden Ticket


Agilent Technologies Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and

Agilent Technologies Increases Cash Dividend to 18 Cents Per Share


Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent

Agilent Announces New ICP-OES Systems with Innovative Instrument Intelligence


Agilent Technologies Inc. (NYSE: A) today announced a new generation of ICP-OES systems for laboratories serving the environmental, food, energy, chemicals, and materials markets.



The new Agilent